PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
KIM vs. ABBV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between KIM and ABBV is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

KIM vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Kimco Realty Corporation (KIM) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

-5.00%0.00%5.00%10.00%15.00%20.00%AugustSeptemberOctoberNovemberDecember2025
4.22%
-0.52%
KIM
ABBV

Key characteristics

Sharpe Ratio

KIM:

0.56

ABBV:

0.39

Sortino Ratio

KIM:

0.90

ABBV:

0.64

Omega Ratio

KIM:

1.11

ABBV:

1.10

Calmar Ratio

KIM:

0.44

ABBV:

0.49

Martin Ratio

KIM:

1.90

ABBV:

1.23

Ulcer Index

KIM:

6.18%

ABBV:

7.61%

Daily Std Dev

KIM:

21.01%

ABBV:

23.74%

Max Drawdown

KIM:

-85.65%

ABBV:

-45.09%

Current Drawdown

KIM:

-13.69%

ABBV:

-15.16%

Fundamentals

Market Cap

KIM:

$14.85B

ABBV:

$302.80B

EPS

KIM:

$0.54

ABBV:

$2.86

PE Ratio

KIM:

40.80

ABBV:

59.91

PEG Ratio

KIM:

86.31

ABBV:

0.40

Total Revenue (TTM)

KIM:

$1.52B

ABBV:

$41.23B

Gross Profit (TTM)

KIM:

$602.35M

ABBV:

$30.76B

EBITDA (TTM)

KIM:

$937.13M

ABBV:

$17.62B

Returns By Period

In the year-to-date period, KIM achieves a -5.98% return, which is significantly lower than ABBV's -2.66% return. Over the past 10 years, KIM has underperformed ABBV with an annualized return of 2.52%, while ABBV has yielded a comparatively higher 14.98% annualized return.


KIM

YTD

-5.98%

1M

-9.82%

6M

4.22%

1Y

13.80%

5Y*

6.17%

10Y*

2.52%

ABBV

YTD

-2.66%

1M

0.78%

6M

-0.52%

1Y

9.98%

5Y*

19.25%

10Y*

14.98%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

KIM vs. ABBV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KIM
The Risk-Adjusted Performance Rank of KIM is 6464
Overall Rank
The Sharpe Ratio Rank of KIM is 6868
Sharpe Ratio Rank
The Sortino Ratio Rank of KIM is 5959
Sortino Ratio Rank
The Omega Ratio Rank of KIM is 5757
Omega Ratio Rank
The Calmar Ratio Rank of KIM is 6767
Calmar Ratio Rank
The Martin Ratio Rank of KIM is 6868
Martin Ratio Rank

ABBV
The Risk-Adjusted Performance Rank of ABBV is 6161
Overall Rank
The Sharpe Ratio Rank of ABBV is 6464
Sharpe Ratio Rank
The Sortino Ratio Rank of ABBV is 5353
Sortino Ratio Rank
The Omega Ratio Rank of ABBV is 5656
Omega Ratio Rank
The Calmar Ratio Rank of ABBV is 6969
Calmar Ratio Rank
The Martin Ratio Rank of ABBV is 6363
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

KIM vs. ABBV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Kimco Realty Corporation (KIM) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for KIM, currently valued at 0.56, compared to the broader market-2.000.002.000.560.39
The chart of Sortino ratio for KIM, currently valued at 0.90, compared to the broader market-4.00-2.000.002.004.000.900.64
The chart of Omega ratio for KIM, currently valued at 1.11, compared to the broader market0.501.001.502.001.111.10
The chart of Calmar ratio for KIM, currently valued at 0.44, compared to the broader market0.002.004.006.000.440.49
The chart of Martin ratio for KIM, currently valued at 1.90, compared to the broader market-30.00-20.00-10.000.0010.0020.001.901.23
KIM
ABBV

The current KIM Sharpe Ratio is 0.56, which is higher than the ABBV Sharpe Ratio of 0.39. The chart below compares the historical Sharpe Ratios of KIM and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.501.001.502.002.50AugustSeptemberOctoberNovemberDecember2025
0.56
0.39
KIM
ABBV

Dividends

KIM vs. ABBV - Dividend Comparison

KIM's dividend yield for the trailing twelve months is around 4.40%, more than ABBV's 3.67% yield.


TTM20242023202220212020201920182017201620152014
KIM
Kimco Realty Corporation
4.40%4.14%4.79%3.97%2.76%3.60%5.41%7.65%6.01%4.11%3.68%3.64%
ABBV
AbbVie Inc.
3.67%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%

Drawdowns

KIM vs. ABBV - Drawdown Comparison

The maximum KIM drawdown since its inception was -85.65%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for KIM and ABBV. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-13.69%
-15.16%
KIM
ABBV

Volatility

KIM vs. ABBV - Volatility Comparison

Kimco Realty Corporation (KIM) has a higher volatility of 7.17% compared to AbbVie Inc. (ABBV) at 5.54%. This indicates that KIM's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%AugustSeptemberOctoberNovemberDecember2025
7.17%
5.54%
KIM
ABBV

Financials

KIM vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between Kimco Realty Corporation and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab